Beilstein J. Org. Chem. 2011, 7, 759–766.
Synthesis of aza-Michael adduct diastereoisomers
4c
3.85–3.75 (m, 1H, CHCF3), 3.39 (dd, J = 7.3 Hz, J = 5.8 Hz,
1H, NCH2CH), 3.16–3.11 (m, 1H, NCH2CH), 1.64 (d, J = 7.0
General procedure with α-(trifluoromethyl)acrylic acid 2 (236 Hz, 3H, CHCH3); 13C NMR (125 MHz, CDCl3) 159.4 (q, J =
mg, 1.69 mmol), NaHCO3 (142 mg, 1.685 mmol) and (R)-1- 4.0 Hz), 139.3 (C-Ar), 128.9 (C-Ar), 128.0 (C-Ar), 126.6
naphthylethylamine (295.4 mg, 1.685 mmol) in methanol (10 (C-Ar), 123.9 (q, J = 275 Hz, CF3), 52.0 (PhCHCH3), 51.1 (q, J
mL), gave after 96 h 550 mg (98%) of the title compound as a = 30.1 Hz, CHCF3), 37.6 (q, J = 3.1 Hz, NCH2CH), 18.2
mixture of diastereoisomers (89% purity). The material was (CHCH3); 19F NMR (470 MHz, CDCl3) −68.72 (d, J = 8.8 Hz,
used without further purification. 1H NMR (400 MHz, CD3OD) CHCF3); HRMS–ESI (m/z): Calcd for C12H12NOF3Na,
8.20 (t, J = 8.2 Hz, 1H, H-Ar), 7.91–7.86 (m, 1H, Ar), 266.0769; found, 266.0769.
7.83–7.79 (m, 1H, Ar), 7.72–7.68 (m, 1H, Ar), 7.59–7.46 (m,
3H, Ar), 4.99–4.88 (m, 1H, PhCHCH3), 3.35–3.22 (m, 1H, Minor isomer (αS,3R)-5a (29 mg, 14%): [α]D20 −36.7 (c 0.09,
CH2CHCF3), 3.21–3.09 (m, 1H, NCH2CH), 3.03–2.94 (m, 1H, CH2Cl2); IR (neat): 2976 (s), 1756 (vs), 1184 (s), 1119 (s), 700
NCH2CH), 1.57 and 1.56 (d, J = 6.7 Hz, 3H); 13C NMR (100 (s) cm−1; 1H NMR (500 MHz, CDCl3) 7.42–7.27 (m, 5H, Ar),
MHz, CD3OD) 172.2 (COONa), 172.0 (COONa), 139.5 (C-Ar), 4.94 (q, J = 7.0 Hz, 1H, ArCHCH3), 3.80–3.71 (m, 1H,
138.9 (C-Ar), 135.5 (C-Ar), 132.48 (C-Ar), 132.45 (C-Ar), CHCF3), 3.30 (dd, J = 6.5 Hz, J = 2.2 Hz, 1H, NCH2CH), 3.22
130.08 (C-Ar), 135.05 (C-Ar), 129.2 (C-Ar), 129.15 (C-Ar), (dd, J = 7.2 Hz, J = 6.0 Hz, 1H, NCH2CH), 1.67 (d, J = 7.1 Hz,
127.5 (C-Ar), 127.4 (C-Ar), 126.8 (C-Ar), 126.75 (C-Ar), 126.7 3H, CHCH3); 13C NMR (125 MHz, CDCl3) 159.3 (q, J = 4.2
(C-Ar), 126.6 (C-Ar), 124.2 (C-Ar), 123.7 (C-Ar), 123.5 Hz), 139.3 (C-Ar), 129.0 (C-Ar), 128.1 (C-Ar), 126.7 (C-Ar),
(C-Ar), 54.5 (PhCHCH3), 54.1 (PhCHCH3), 52.5 (q, J = 25.0 123.8 (q, J = 275 Hz, CF3), 52.5 (PhCHCH3), 51.3 (q, J = 30.8
Hz, CHCF3), 52.2 (q, J = 25.0 Hz, CHCF3), 45.2 (q, J = 3.0 Hz, Hz, CHCF3), 37.7 (q, J = 3.1 Hz, NCH2CH), 18.4 (CHCH3);
NCH2CH), 44.9 (q, J = 3.0 Hz, NCH2CH), 22.51 (CHCH3), 19F NMR (470 MHz, CDCl3) −68.85 (d, J = 9.1 Hz, CHCF3);
22.46 (CHCH3); 19F NMR (375 MHz, CD3OD) −69.0 (d, J = HRMS–ESI (m/z): Calcd for C12H12NOF3Na, 266.0769; found,
9.7 Hz, CHCF3), −69.1 (d, J = 9.7 Hz, CHCF3); HRMS–ESI 266.0766.
(m/z): Calcd for C16H16NO2F3Na, 334.1031; found, 334.1031.
Preparation of diastereoisomers 5b
General method for cyclisation of adducts 4 to
Sodium salt 4b (1.18 g, 3.77 mmol) and SOCl2 (1.36 mL,
β-lactams 5
18.8 mmol) in DCM (100 mL) and DMF (5 drops), followed by
The sodium salt of 4 (8.00 mmol) was dissolved in dry DCM Et3N (2.6 mL, 39.8 mmol), gave 5b as a colourless oil.
(100 mL) and DMF (5 drops) was added. The mixture was
cooled to 0 °C and then SOCl2 (2.78 mL, 40.00 mmol, 5 equiv) Major isomer (αS,3S)-5b (447 mg, 43%): [α]D20 +96.5 (c 0.31,
added dropwise. The reaction mixture was warmed to RT and CH2Cl2); IR (neat): 2980 (s), 1756 (vs), 1612 (s), 1515 (s),
stirred overnight. Solvent and excess of SOCl2 were removed 1372 (s), 1180 (s), 1120 (s), 1031 (s), 1010 (s), 835 (s) cm−1;
under reduced pressure and the oily residue was redissolved in 1H NMR (400 MHz, CDCl3) 7.30–7.25 (m, 2H, Ar), 6.95–6.90
dry DCM (10 mL). The solution was heated to reflux while (m, 2H, Ar), 4.94 (q, J = 6.5 Hz, 1H, PhCHCH3), 3.85 (s, 3H,
Et3N (5.38 mL, 39.75 mmol, 5 equiv) was added. The PhOCH3), 3.84–3.73 (m, 1H, CH2CHCF3), 3.36 (dd, J = 6.0
reaction mixture was diluted with water (10 mL) and Hz, J = 6.0 Hz, 1H, NCH2CH), 3.11 (dd, J = 6.3 Hz, J = 2.6 Hz,
extracted into DCM (3 × 10 mL). The combined organic 1H, NCH2CH), 1.61 (d, J = 7.1 Hz, 3H, CHCH3); 13C NMR
phases were washed with brine (10 mL), dried (Na2SO4) and (100 MHz, CDCl3) 159.7 (NCOCH), 131.6 (C-Ar), 128.3
solvent was removed under reduced pressure to give 4 as a mix- (C-Ar), 124.4 (q, J = 275 Hz, CF3) 114.6 (C-Ar), 55.8
ture of two isomers, which were then separated by chromatog- (PhCHCH3), 51.7 (PhOCH3), 51.4 (q, J = 30.2 Hz, CHCF3),
raphy.
37.9 (q, J = 3.3 Hz, NCH2CH), 18.6 (CHCH3);
19F NMR (376 MHz, CDCl3) −69.2 (d, J = 8.1 Hz, CHCF3);
HRMS–ESI (m/z): Calcd for C13H14NO2F3Na, 296.0874;
Preparation of diastereoisomers 5a
Sodium salt 4a (245 mg, 0.86 mmol) and SOCl2 (310 μL, 4.3 found, 296.0868.
mmol) in DCM (20 mL), followed by Et3N (600 μL, 4.3 mmol),
gave 5 as a yellow oily solid.
Minor isomer (αS,3R)-5b (140 mg, 14%): [α]D20 −42.1 (c 0.18,
CH2Cl2); IR (neat): 2975 (s), 1760 (vs), 1611 (s), 1515 (s),
Major isomer (αS,3S)-5a (91 mg, 43%): [α]D20 −88.5 (c 0.34, 1370 (s), 1244 (vs), 1121 (s), 1031 (s), 1010 (s), 833 (s) cm−1;
CH2Cl2); IR (neat): 2978 (s), 1753 (vs), 1180 (s), 1120 (s), 892 1H NMR (400 MHz, CDCl3) 7.25–7.22 (m, 2 H, Ar), 6.94–6.90
(s), 699 (s), 571 (s) cm−1; 1H NMR (500 MHz, CDCl3) (m, 2H, Ar), 4.91 (q, J = 7.0 Hz, 1H, PhCHCH3), 3.83 (s, 3H,
7.42–7.27 (m, 5H, Ar), 4.97 (q, J = 7.0 Hz, 1H, ArCHCH3), PhOCH3), 3.78–3.68 (m, 1H, CH2CHCF3), 3.27 (dd, J = 6.4
764